ISRCTN91141483已完成未知
Sublingual immunotherapy with house dust mite allergen in children with allergic rhinitis: randomised double-blind placebo-controlled trial
Artu Biologicals Europe B.V. (Netherlands)0 个研究点目标入组 251 人开始时间: 2005年12月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 251
研究概览
简要总结
2008 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/18937864 protocol 2012 Results article in https://pubmed.ncbi.nlm.nih.gov/22017365/ (added 27/10/2022)
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age: 6 - 18 years
- •2. History of allergic rhinitis for at least one year
- •3. Positive RAST for house dust mite allergy (Y2+)
- •4. No use of nasal steroids in month before start of baseline measurements
- •5. Symptom score of at least 4/12 (four nasal symptoms with scores ranging 0 - 3)
- •6. Informed consent
排除标准
- •1. Severe asthma
- •2. Allergic sensitivity to pets, in case these are present in the family home
- •3. Planned surgery of nasal cavity in the course of the study
- •4. Having received immunotherapy in past three years
- •5. Contraindications to sublingual immunotherapy
研究者
相似试验
招募中
不适用
Sublingual immunotherapy with house dust mite allergen in children with allergic rhinitis: randomised double-blind placebo-controlled trial.allergic rhinitis related to house dust mite allergyNL-OMON28314ARTU Biologicals Europe BV256
已完成
不适用
Sublingual immunotherapy for housedust miteRespiratory: Housedust allergyRespiratoryHousedust allergyISRCTN96862420Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)80
已完成
4 期
House Dust Mite SLIT in Elderly PatientsAllergic RhinitisNCT01605760Medical University of Silesia111
已完成
不适用
Immunotherapy Administered Under the Tongue to Treat Dust Mite AllergyAsthmaNCT00200850University of Wisconsin, Madison31
进行中（未招募）
1 期
Prevention of allergy development in preschool childreEUCTR2016-002844-18-ATMedical University of Vienna, Dpt. of Pediatrics